Chronic Lymphocytic Leukemia | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Chronic Lymphocytic Leukemia

Featuring perspectives from Drs Jennifer Brown and Deborah Stephens, including the following topics:

• Introduction: First-Line Treatment of Chronic Lymphocytic Leukemia (0:00)
• Combining Bruton Tyrosine Kinase (BTK) Inhibitors with Venetoclax; Venetoclax Consolidation (36:57)
• Noncovalent BTK Inhibitors; Pirtobrutinib (42:59)
• CAR T-Cell Therapy; Lisocabtagene Maraleucel (51:26)
• Richter's Transformation (56:31)

CME information and select publications